Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Post by LordoftheMarketon Mar 23, 2018 8:59am
202 Views
Post# 27768355

Its going to be a Massive day for the whole sector! :-)

Its going to be a Massive day for the whole sector! :-)

Isodiol International to acquire U.S. vape seller

2018-03-23 06:37 ET - News Release

Mr. Marcos Agramont reports

ISODIOL INTERNATIONAL INC. SIGNS LETTER OF INTENT TO ACQUIRE LEADING SPECIALTY VAPE RETAILER KURE CORP

Isodiol International Inc. has signed a letter of intent to acquire 100 per cent of KURE Corp., a leading specialty vape retailer headquartered in Charlotte, N.C., with locations in the United States and annualized unaudited fiscal 2018 revenue of $8.8-million (U.S.). KURE specializes in the retailing of vaporizers and e-cigarettes, e-juices, and related accessories.

KURE set out to change the current state of the vape shop industry with the introduction of KURE Vaporium & Lounge, a modern and sophisticated retail environment and lounge catering to the vaping community. By elevating the environment and customer experience, KURE has paved a completely new path to the rapidly growing vaping and e-cigarette industry and operates a total of 12 e-juice bars and lounges today, with plans for international expansion.

"KURE's executives are highly experienced business entrepreneurs that have done a tremendous job in building the KURE brand," said chief executive officer of Isodiol Marcos Agramont. "Not only does this further entrench our footprint in the vaping and e-cigarette industry, but through KURE retail stores, the company will set up its own distribution channels for its family of brands, including ISO-Sport and Be Tru Wellness."

"We believe KURE to be the Starbucks of the specialty retail vape industry. The KURE brand has been carefully built thanks to our incredibly loyal customer following. The KURE philosophy is to serve our customers the best selection of vape juices and hardware by the most knowledgeable customer service professionals, our own Kurators, in an unmatched atmosphere in every KURE store. With over 200,000 customer transactions per year and growing, KURE's knowledge base in the vape industry is exceptional. In joining the Isodiol family, we will now be able to provide our devout customers the very best CBD products on the market. We intend to rapidly expand the KURE brand worldwide," said Craig Brewer, chairman and CEO of KURE Corp.

All KURE products are available on-line and throughout its store locations across the United States. KURE Vaporium & Lounge, KURE Society, Kuriousity and Kurators are all respective trademarks of KURE Corp. Its e-juices can be purchased prebottled or freshly mixed by its staff of Kurators, well-trained and experienced mixologists who can blend over 500,000 unique flavours from the KURE Juice On Tap bar. These KURE e-juices are skillfully blended and served while customers shop, lounge and enjoy a selection of coffees, beverages and snacks, or simply vape.

"When we acquired Bradley's Bioscience, we were excited about the prospects of providing safer alternatives to smoking, while at the same time being able to enter a market poised to be worth over $60 billion by 2025," said Mr. Agramont. "With this partnership, we will further entrench our footprint in this fast-growing industry, and we look forward to the global opportunities it presents for the company."

Once finalized, the terms of this agreement will be defined upon the definitive agreement, which is anticipated by the end of April, 2018.

About Isodiol International Inc.

Isodiol International is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products. Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99-per-cent-pure, bioactive pharmaceutical grade cannabinoids, microencapsulations and nanotechnology for the highest-quality consumable and topical skin care products.

We seek Safe Harbor.


 

Bullboard Posts